Literature DB >> 32034249

Patients with non-Sjögren's sicca report poorer general and oral health-related quality of life than patients with Sjögren's syndrome: a cross-sectional study.

B Tashbayev1, T Garen2, Ø Palm2, X Chen3, B B Herlofson3, A Young4, L H Hove4, M Rykke4, P B Singh3, L A Aqrawi3, Ø A Utheim5, T P Utheim6,7, J L Jensen3.   

Abstract

Understanding the impact of the disease on quality of life is crucial in patient management. In this cross-sectional study, general and oral health-related quality of life questionnaires, and thorough examinations of oral and ocular dryness were performed in age- and sex-matched patients with primary Sjögren's syndrome (pSS group), non-Sjögren's syndrome sicca (non-SS group) and healthy controls. General and oral health-related quality of life were investigated with the 36-Item Short Form Health Survey and the 14-Item Oral Health Impact Profile questionnaires, respectively. Subjective symptoms of xerostomia and ocular dryness were recorded using the Summated Xerostomia Inventory and Ocular Surface Disease Index, respectively. Clinical examinations included evaluation of clinical oral dryness scores, candida counts, unstimulated and stimulated saliva secretory rates, tear osmolarity, tear film break-up time, Schirmer I test and ocular surface staining. Both patient groups had pronounced signs and symptoms of xerostomia and ocular dryness. Even though the non-SS patients had less severe clinical signs than the pSS patients, they demonstrated much poorer general and oral health-related quality of life. In conclusion, non-SS patients require more attention in order to improve their quality of life.

Entities:  

Mesh:

Year:  2020        PMID: 32034249      PMCID: PMC7005680          DOI: 10.1038/s41598-020-59078-0

Source DB:  PubMed          Journal:  Sci Rep        ISSN: 2045-2322            Impact factor:   4.379


  59 in total

Review 1.  Sjögren's syndrome: pathogenesis.

Authors:  K Tabbara; N Sharara
Journal:  Eur J Ophthalmol       Date:  1999 Jan-Mar       Impact factor: 2.597

Review 2.  A review and update of Sjögren's syndrome: manifestations, diagnosis, and treatment.

Authors:  S Carsons
Journal:  Am J Manag Care       Date:  2001-09       Impact factor: 2.229

Review 3.  Classification criteria for Sjögren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group.

Authors:  C Vitali; S Bombardieri; R Jonsson; H M Moutsopoulos; E L Alexander; S E Carsons; T E Daniels; P C Fox; R I Fox; S S Kassan; S R Pillemer; N Talal; M H Weisman
Journal:  Ann Rheum Dis       Date:  2002-06       Impact factor: 19.103

4.  Tear lipocalin and lysozyme in Sjögren and non-Sjögren dry eye.

Authors:  Barbary Caffery; Elizabeth Joyce; Adrienne Boone; Allan Slomovic; Trefford Simpson; Lyndon Jones; Michelle Senchyna
Journal:  Optom Vis Sci       Date:  2008-08       Impact factor: 1.973

Review 5.  TFOS DEWS II pathophysiology report.

Authors:  Anthony J Bron; Cintia S de Paiva; Sunil K Chauhan; Stefano Bonini; Eric E Gabison; Sandeep Jain; Erich Knop; Maria Markoulli; Yoko Ogawa; Victor Perez; Yuichi Uchino; Norihiko Yokoi; Driss Zoukhri; David A Sullivan
Journal:  Ocul Surf       Date:  2017-07-20       Impact factor: 5.033

6.  Risk factors for caries development in primary Sjogren syndrome.

Authors:  Nicola Berman; Frederick Vivino; Joshua Baker; Jonathan Dunham; Andres Pinto
Journal:  Oral Surg Oral Med Oral Pathol Oral Radiol       Date:  2019-04-26

Review 7.  Sjögren syndrome.

Authors:  K F Tabbara; C L Vera-Cristo
Journal:  Curr Opin Ophthalmol       Date:  2000-12       Impact factor: 3.761

Review 8.  Treatment of primary Sjögren syndrome: a systematic review.

Authors:  Manuel Ramos-Casals; Athanasios G Tzioufas; John H Stone; Antoni Sisó; Xavier Bosch
Journal:  JAMA       Date:  2010-07-28       Impact factor: 56.272

9.  Discrimination between Sjögren's and non-Sjögren's sicca syndrome by sialoscintigraphy and antibodies against alpha-fodrin and Ro/La autoantigens.

Authors:  K-S Chen; M-C Jiang; C-J Li; O-K Liu; C-S S Tsai
Journal:  J Int Med Res       Date:  2009 Jul-Aug       Impact factor: 1.671

10.  Keratoconjunctivitis sicca and buccoglossopharyngitis sicca with enlargement of parotid glands; report of two cases of Sjögren's syndrome, with pathologic study of a lacrimal gland and the parotid glands in one case.

Authors:  F C LUTMAN; B V FAVATA
Journal:  Arch Ophthal       Date:  1946-03
View more
  7 in total

1.  The relationship between ocular and oral dryness in a cohort from the 65-year-old population in Norway.

Authors:  Håvard Hynne; Behzod Tashbayev; My Tien Diep; Anne Thea Tveit Sødal; Reza A Badian; Xiangjun Chen; Xiaoran Lai; Tor P Utheim; Lene Hystad Hove; Janicke Liaaen Jensen
Journal:  Sci Rep       Date:  2022-06-13       Impact factor: 4.996

2.  Sjögren's and non-Sjögren's sicca share a similar symptom burden but with a distinct symptom-associated proteomic signature.

Authors:  Valentina Pucino; Jason D Turner; Saba Nayar; Florian Kollert; Saaeha Rauz; Andrea Richards; Jon Higham; Ana Poveda-Gallego; Simon J Bowman; Francesca Barone; Benjamin A Fisher
Journal:  RMD Open       Date:  2022-05

3.  National Sjögren's Foundation Survey: Burden of Oral and Systemic Involvement on Quality of Life.

Authors:  Sara S McCoy; Christie M Bartels; Ian J Saldanha; Vatinee Y Bunya; Esen K Akpek; Matthew A Makara; Alan N Baer
Journal:  J Rheumatol       Date:  2020-09-15       Impact factor: 5.346

4.  Outcomes of Sjögren's versus non-Sjögren's related dry eye in a longitudinal, tertiary clinic-based sample.

Authors:  David Cui; Priya Mathews; Gavin Li; Shanna VanCourt; Esen Akpek
Journal:  PLoS One       Date:  2021-12-17       Impact factor: 3.240

5.  Saliva Metabolomics in Dry Mouth Patients with Head and Neck Cancer or Sjögren's Syndrome.

Authors:  Håvard Hynne; Elise Mørk Sandås; Katja Benedikte Prestø Elgstøen; Helge Rootwelt; Tor P Utheim; Hilde Kanli Galtung; Janicke Liaaen Jensen
Journal:  Cells       Date:  2022-01-19       Impact factor: 6.600

6.  Regulation of MMP9 transcription by ETS1 in immortalized salivary gland epithelial cells of patients with salivary hypofunction and primary Sjögren's syndrome.

Authors:  Braxton Noll; Farah Bahrani Mougeot; Michael T Brennan; Jean-Luc C Mougeot
Journal:  Sci Rep       Date:  2022-08-25       Impact factor: 4.996

7.  Saliva substitute mouthwash in nasopharyngeal cancer survivors with xerostomia: a randomized controlled trial.

Authors:  Dayaabaran Marimuthu; Kong Min Han; Mohd Shawal Firdaus Mohamad; Mawaddah Azman
Journal:  Clin Oral Investig       Date:  2020-11-11       Impact factor: 3.573

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.